Acute Myeloid Leukemia (AML) patients, a diversity of clinical and hematological parameters has been examined for possible value in calculating treatment response and survival. The study was conducted at National…
Acute Myeloid Leukaemia (AML) is frequently associated to normal karyotype and DNMT3A mutations (R882). Since we previously demonstrated distinctive miRNA expression in some AML groups, we study 384 miRNA ... selected…
microRNAs (miRNAs) involved in transformation from myelodysplastic syndrome (MDS) to acute myeloblastic leukemia (AML). Methods: Based on Gene Expression Omnibus (GEO) database (GSE15061), a microarray analysis of AML…
minimal residual disease (MRD) causes relapse after chemotherapy in patients with acute myelogenous leukemia (AML) due to acquired drug resistance - this is induced by the attachment of the integrin receptor ... AS101…
intravenous administration, remains the primary modality of treatment for patients with acute myeloid leukemia (AML). Chemotherapeutic agents when given intravenously are diluted many fold as they enter into the…
unmet need for new effective and less toxic therapies for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients. This is particularly important for the elderly patients who are often ... number of…
Acute Myeloid Leukemia (AML) is a quickly aggressive hematopoietic disorder that progress due to the accumulation and clonal expansion of immature myeloid cells. Despite the latest developments in AML treatment ... such…
them the kidneys. During follow-up the abdominal Computer Tomography (CT) showed bilateral angiolipomatosis (AML) and a fat-poor mass with a different solid aspect on the left side ... poor AML can be a challenge to…
relevant time frames. I received data on 12 individuals, including children, diagnosed with AML who lived within one mile of the old refinery for an average of 25.25 years ... populations for all leukemia is 3.11. The…
most important roles for the classification and risk stratification of acute myeloid leukemia (AML). AML patients with a favorable risk cytogenetic profile are associated with relatively good responses to chemotherapy…
though there has been improvements in the understanding and treatment of acute myeloid leukemia (AML), not much advances are noted when it comes to outcome and survival. It is still ... substantial the association of…
Wilms tumor 1 gene (WT1) is implicated in the prognosis of acute myeloid leukemia (AML) with high expression predicting disease progression, as well as being intensively studied as a potential ... described. The AWT1…
studies have shown alvocidib to be highly effective in both frontline and relapsed/refractory AML when sequentially administered before cytarabine and mitoxantrone (ACM). In frontline patients, ACM resulted ... with…
epithelial cancer cells. In this study, we studied Ig expression in acute myeloid leukemia (AML). We found that Ig was expressed at a high frequency and level in AML cell ... flow cytometry. We further assessed…
that is based on peer reviewed, recent articles. Acute myeloid leukemia not otherwise specified (AML, NOS) is a category that will continue to diminish as more cytogenetic subgroups are being ... with recurrent…
relevance of recurrent molecular abnormalities in cytogenetically normal (CN) acute myeloid leukemia (AML) was recently acknowledged by the inclusion of molecular markers such as NPM1, FLT3, and CEBPA ... apoptosis. We…
advance targeted therapy-development by exploring non-genetic approaches to maintain acute myeloid leukemia (AML) immature progenitors that exist to varying degrees in primary leukapheresis samples. Cells from AML…
Acute myeloid leukemia (AML) is the second most common form of childhood leukemia and has the worst prognosis of all major childhood cancers. Improving the treatment outcome for patients with ... AML remains a major…
Introduction: Central Nervous System involvement (CNSi) in patients with Acute Myeloid Leukemia (AML) rarely occurs. It is not well characterized clinically and lacks standardized treatments. Patients and methods: A…
Background: Prognostic stratification of cytogenetic normal acute myeloid leukemia (CN-AML) is an area of active research. Aim: The aim of this study was to determine the prognostic importance ... meningioma 1 (MN1)…
Background: Patients with Acute Myeloid Leukemia (AML) experience profound neutropenia; infections remain the leading cause of morbidity and mortality. Transfusion of functional non-irradiated allogeneic granulocytes…
methyltransferase genes. Gene alterations of these enzymes have been related to Acute Myeloid Leukemia (AML)1,2. DNMT3A plays an important role in de novo methylation, paternal and maternal imprinting ... quantification…
This lecture will address immune therapeutic approaches for AML treatment strategies comparing expression patterns of NPM1 mut and NPM1 wt AML patients, in order to look for new target structures ... focus of interest…
promising clinical success in solid tumors [1,2] its effectiveness in Acute Myeloid Leukemia (AML) remains limited, AML is considered an immunologically 'cold' tumor [3] despite evidence ... patients. Although advances…
evolving methods that outpace current regulations. Despite the implementation of Anti-Money Laundering (AML) compliance measures such as Know Your Customer (KYC) and Customer Due Diligence (CDD), sophisticated…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.